Powder: -20°C for 3 years
In solvent: -80°C for 2 years
AG473 is an inhibitor of EGFR in human A431 cells.
Description | AG473 is an inhibitor of EGFR in human A431 cells. |
In vivo | Expressed the Ag473 lipoprotein from Neisseria meningitides, flagellin FlaB from Vibrio vulnificus and heat shock protein 70 from Mycobacterium tuberculosis (mHsp70) in Escherichia coli as single proteins and fusion proteins with VP2 protein of infectious bursal disease virus (IBDV).?Both cellular and humoral adjuvanticities of the three TLR ligands were compared by immunization of mice in two different ways.?Among the three co-administered TLR ligands, recombinant Ag473 lipoprotein exhibited the highest cellular and humoral adjuvanticities, including promotion of IL-4, IL-12, IFN-γ and IBDV VP2-specific antibody production.?Among the three genetically fused TLR ligands, fusion with Ag473 D1 domain exhibited the highest cellular and humoral adjuvanticities. |
Synonyms | AG473 |
Molecular Weight | 265.26 |
Formula | C16H11NO3? |
CAS No. | 133550-22-8 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EGFR-IN-16 133550-22-8 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR FGFR Epidermal growth factor receptor inhibit Inhibitor ErbB-1 AG473 HER1 EGFRIN16 EGFR IN 16 inhibitor